These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19418567)

  • 1. Pediatric Crohn's disease activity at diagnosis, its influence on pediatrician's prescribing behavior, and clinical outcome 5 years later.
    Mesker T; van Rheenen PF; Norbruis OF; Uitentuis J; Waalkens HJ; Gonera G; van Overbeek LA; Butler J; Rings EH
    Inflamm Bowel Dis; 2009 Nov; 15(11):1670-7. PubMed ID: 19418567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group "growth relapse and outcomes with therapy" (GROWTH CD) study.
    Levine A; Turner D; Pfeffer Gik T; Amil Dias J; Veres G; Shaoul R; Staiano A; Escher J; Kolho KL; Paerregaard A; Martin de Carpi J; Veereman Wauters G; Koletzko S; Shevah O; Finnby L; Sladek M
    Inflamm Bowel Dis; 2014 Feb; 20(2):278-85. PubMed ID: 24390062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and efficacy of azathioprine in pediatric Crohn's disease.
    Riello L; Talbotec C; Garnier-Lengliné H; Pigneur B; Svahn J; Canioni D; Goulet O; Schmitz J; Ruemmele FM
    Inflamm Bowel Dis; 2011 Oct; 17(10):2138-43. PubMed ID: 21910176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
    Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study.
    Burisch J; Bergemalm D; Halfvarson J; Domislovic V; Krznaric Z; Goldis A; Dahlerup JF; Oksanen P; Collin P; de Castro L; Hernandez V; Turcan S; Belousova E; D'Incà R; Sartini A; Valpiani D; Giannotta M; Misra R; Arebi N; Duricova D; Bortlik M; Gatt K; Ellul P; Pedersen N; Kjeldsen J; Andersen KW; Andersen V; Katsanos KH; Christodoulou DK; Sebastian S; Barros L; Magro F; Midjord JM; Nielsen KR; Salupere R; Kievit HA; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Kaimakliotis IP; Schwartz D; Odes S; Lakatos L; Lakatos PL; Langholz E; Munkholm P;
    United European Gastroenterol J; 2020 Oct; 8(8):949-960. PubMed ID: 32715989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
    Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG; Sandborn WJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
    Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
    J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for an uncomplicated long-term course of Crohn's disease: a retrospective analysis.
    Kruis W; Katalinic A; Klugmann T; Franke GR; Weismüller J; Leifeld L; Ceplis-Kastner S; Reimers B; Bokemeyer B
    J Crohns Colitis; 2013 Aug; 7(7):e263-70. PubMed ID: 23182164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease.
    Ma C; Ascoytia C; McCarrier KP; Martin M; Feagan BG; Jairath V
    Dig Dis Sci; 2018 Oct; 63(10):2555-2563. PubMed ID: 29959726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of pediatric Crohn's disease in Belgium.
    De Greef E; Mahachie John JM; Hoffman I; Smets F; Van Biervliet S; Scaillon M; Hauser B; Paquot I; Alliet P; Arts W; Dewit O; Peeters H; Baert F; D'Haens G; Rahier JF; Etienne I; Bauraind O; Van Gossum A; Vermeire S; Fontaine F; Muls V; Louis E; Van de Mierop F; Coche JC; Van Steen K; Veereman G; ;
    J Crohns Colitis; 2013 Dec; 7(11):e588-98. PubMed ID: 23664896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of infliximab in treatment of pediatric Crohn's disease in China].
    Luo Y; Yu J; Zhao H; Peng K; Lou J; Ma M; Chen J
    Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):688-92. PubMed ID: 25476432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children.
    Levine A; Broide E; Stein M; Bujanover Y; Weizman Z; Dinari G; Pacht A; Branski D; Zahavi I
    J Pediatr; 2002 Jan; 140(1):75-80. PubMed ID: 11815767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of current treatments used in clinical practice in a pediatric summer camp population for children with inflammatory bowel disease.
    Rosen D; Kathy-Hoffstadter-Thal ; Bao R; Tomaino J; Ceballos C; Russell GJ; Benkov KJ
    Inflamm Bowel Dis; 2012 Oct; 18(10):1818-24. PubMed ID: 22069120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined azithromycin and metronidazole therapy is effective in inducing remission in pediatric Crohn's disease.
    Levine A; Turner D
    J Crohns Colitis; 2011 Jun; 5(3):222-6. PubMed ID: 21575885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term therapeutic effectiveness of maintenance enteral nutrition for Crohn's disease.
    Konno M; Takahashi M; Toita N; Fujiwara S; Nojima M
    Pediatr Int; 2015 Apr; 57(2):276-80. PubMed ID: 25203356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators--a population-based study.
    Jakobsen C; Munkholm P; Paerregaard A; Wewer V
    Inflamm Bowel Dis; 2011 Aug; 17(8):1731-40. PubMed ID: 21744428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial.
    Prantera C; Cottone M; Pallone F; Annese V; Franzè A; Cerutti R; Bianchi Porro G
    Gastroenterology; 1999 Mar; 116(3):521-6. PubMed ID: 10029609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study.
    Krishnakumar C; Ballengee CR; Liu C; Kim MO; Baker SS; Baldassano RN; Cohen SA; Crandall WV; Denson LA; Dubinsky MC; Evans J; Gokhale R; Griffiths A; Guthery SL; Oliva-Hemker M; Heyman MB; Keljo D; Kellermayer R; Leleiko NS; Mack DR; Markowitz JF; Moulton DE; Noe JD; Otley AR; Patel AS; Pfefferkorn M; Rabizadeh S; Rosh JR; Snapper S; Walters TD; Ziring D; Mondal K; Kappelman MD; Hyams JS; Kugathasan S
    Inflamm Bowel Dis; 2019 Jun; 25(7):1208-1217. PubMed ID: 30601983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy.
    Ruemmele FM; Lachaux A; Cézard JP; Morali A; Maurage C; Giniès JL; Viola S; Goulet O; Lamireau T; Scaillon M; Breton A; Sarles J;
    Inflamm Bowel Dis; 2009 Mar; 15(3):388-94. PubMed ID: 19023899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.